Your browser doesn't support javascript.
loading
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.
Kühne, Lucas; Völker, Linus A; Hagmann, Henning; Hägele, Holger; Osterholt, Thomas; Eichenauer, Dennis A; Thomas, Andreas; Breuer, Johanna; Grüttner, Berthold; Gottschalk, Ingo; Kann, Martin; Benzing, Thomas; Thevis, Mario; Müller, Annette M; Brinkkoetter, Paul T.
Afiliação
  • Kühne L; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Völker LA; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Hagmann H; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Hägele H; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Osterholt T; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Eichenauer DA; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Thomas A; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Breuer J; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Grüttner B; Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Gottschalk I; Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.
  • Kann M; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Benzing T; Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • Thevis M; Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • Müller AM; Department of Obstetrics and Gynecology, University Hospital of Cologne, Cologne, Germany.
  • Brinkkoetter PT; Department of Obstetrics and Gynecology, University Hospital of Cologne, Cologne, Germany.
Br J Haematol ; 196(3): e30-e33, 2022 02.
Article em En | MEDLINE | ID: mdl-34585743
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Hematológicas na Gravidez / Púrpura Trombocitopênica Trombótica / Fator de von Willebrand / Anticorpos de Domínio Único Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Hematológicas na Gravidez / Púrpura Trombocitopênica Trombótica / Fator de von Willebrand / Anticorpos de Domínio Único Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article